Medical therapy is best for atherosclerotic renal artery stenosis: Arguments for

作者: RA Annigeri

DOI: 10.4103/0971-4065.91177

关键词: MedicineRegimenBlood pressureRenal arteryHeart failureInternal medicineCardiologyRisk factorRandomized controlled trialAngioplastyRenal function

摘要: Atherosclerotic renal artery stenosis (ARAS) is a common condition that causes hypertension and reduction in the glomerular filtration rate an independent risk factor for death. Despite high technical success, clinical benefit of (RA) angioplasty with stenting ARAS remains doubtful. The published randomized trials provide no support notion significantly improves blood pressure, preserves function, or reduces episodes congestive heart failure patients ARAS. RA associated procedure-related morbidity mortality. Agents to block renin-angiotensin-aldosterone system improve outcome should be part multifaceted medical regimen Medical therapy effectively controls atherosclerotic renovascular disease at all levels vasculature hence best

参考文章(25)
Viswanathan Mohan, Raj Deepa, Subramaniam Shanthi Rani, Gopal Premalatha, Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). Journal of the American College of Cardiology. ,vol. 38, pp. 682- 687 ,(2001) , 10.1016/S0735-1097(01)01415-2
Revascularization versus medical therapy for renal-artery stenosis. The New England Journal of Medicine. ,vol. 361, pp. 1953- 1962 ,(2009) , 10.1056/NEJMOA0905368
Michael T. Caps, Claudio Perissinotto, R. Eugene Zierler, Nayak L. Polissar, Robert O. Bergelin, Michael J. Tullis, Kim Cantwell-Gab, Robert C. Davidson, D. Eugene Strandness, Prospective Study of Atherosclerotic Disease Progression in the Renal Artery Circulation. ,vol. 98, pp. 2866- 2872 ,(1998) , 10.1161/01.CIR.98.25.2866
Daniel G. Hackam, Minh L. Duong-Hua, Muhammad Mamdani, Ping Li, Sheldon W. Tobe, J. David Spence, Amit X. Garg, Angiotensin inhibition in renovascular disease: a population-based cohort study. American Heart Journal. ,vol. 156, pp. 549- 555 ,(2008) , 10.1016/J.AHJ.2008.05.013
Michael T. Caps, R. Eugene Zierler, Nayak L. Polissar, Robert O. Bergelin, Kirk W. Beach, Kim Cantwell-Gab, Alder Casadei, Robert C. Davidson, D. Eugene Strandness, Risk of atrophy in kidneys with atherosclerotic renal artery stenosis Kidney International. ,vol. 53, pp. 735- 742 ,(1998) , 10.1046/J.1523-1755.1998.00805.X
Lance D. Dworkin, Timothy Murphy, Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis? American Journal of Kidney Diseases. ,vol. 56, pp. 259- 263 ,(2010) , 10.1053/J.AJKD.2010.04.005
Philip A. Kalra, Haifeng Guo, David T. Gilbertson, Jiannong Liu, Shu-Cheng Chen, Areef Ishani, Allan J. Collins, Robert N. Foley, Atherosclerotic renovascular disease in the United States. Kidney International. ,vol. 77, pp. 37- 43 ,(2010) , 10.1038/KI.2009.406
Brigit C. van Jaarsveld, Pieta Krijnen, Herman Pieterman, Frans H.M. Derkx, Jaap Deinum, Cornelis T. Postma, Ad Dees, Arend J.J. Woittiez, Anton K.M. Bartelink, Arie J. Man in `t Veld, Maarten A.D.H. Schalekamp, The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis The New England Journal of Medicine. ,vol. 342, pp. 1007- 1014 ,(2000) , 10.1056/NEJM200004063421403
Mitchell D. Weinberg, Jeffrey W. Olin, Stenting for atherosclerotic renal artery stenosis: one poorly designed trial after another. Cleveland Clinic Journal of Medicine. ,vol. 77, pp. 164- 171 ,(2010) , 10.3949/CCJM.77A.10001
J Webster, , F Marshall, M Abdalla, A Dominiczak, R Edwards, CG Isles, H Loose, J Main, P Padfield, IT Russell, B Walker, M Watson, R Wilkinson, Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension. ,vol. 12, pp. 329- 335 ,(1998) , 10.1038/SJ.JHH.1000599